Aspergillus infections in cystic fibrosis

Jill King, Shan F Brunel, Adilia Warris

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Patients with cystic fibrosis (CF) suffer from chronic lung infection and airway inflammation. Respiratory failure secondary to chronic or recurrent infection remains the commonest cause of death and accounts for over 90% of mortality. Bacteria as Staphylococcus aureus, Pseudomonas aeruginosa and Burkholderia cepacia complex have been regarded the main CF pathogens and their role in progressive lung decline has been studied extensively. Little attention has been paid to the role of Aspergillus spp. and other filamentous fungi in the pathogenesis of non-ABPA (allergic bronchopulmonary aspergillosis) respiratory disease in CF, despite their frequent recovery in respiratory samples. It has become more apparent however, that Aspergillus spp. may play an important role in chronic lung disease in CF. Research delineating the underlying mechanisms of Aspergillus persistence and infection in the CF lung and its link to lung deterioration is lacking. This review summarizes the Aspergillus disease phenotypes observed in CF, discusses the role of CFTR (cystic fibrosis transmembrane conductance regulator)-protein in innate immune responses and new treatment modalities.
Original languageEnglish
Pages (from-to)S50-S55
Number of pages6
JournalJournal of Infection
Volume72
Issue numberSupplement 5
Early online date11 May 2016
DOIs
Publication statusPublished - 5 Jul 2016

Fingerprint

Aspergillus
Cystic Fibrosis
Infection
Lung
Burkholderia cepacia complex
Allergic Bronchopulmonary Aspergillosis
Burkholderia cepacia
Cystic Fibrosis Transmembrane Conductance Regulator
Innate Immunity
Respiratory Insufficiency
Pseudomonas aeruginosa
Lung Diseases
Staphylococcus aureus
Cause of Death
Chronic Disease
Fungi
Inflammation
Bacteria
Phenotype
Mortality

Keywords

  • aspergillus
  • aspergillus fumigatus
  • aspergillosis
  • cystic fibrosis
  • allergic bronchopulmonary aspergillosis
  • CFTR

Cite this

Aspergillus infections in cystic fibrosis. / King, Jill; Brunel, Shan F; Warris, Adilia.

In: Journal of Infection, Vol. 72, No. Supplement 5, 05.07.2016, p. S50-S55.

Research output: Contribution to journalArticle

King, Jill ; Brunel, Shan F ; Warris, Adilia. / Aspergillus infections in cystic fibrosis. In: Journal of Infection. 2016 ; Vol. 72, No. Supplement 5. pp. S50-S55.
@article{49a9a33834ff4c839c4c9665fd6b78ab,
title = "Aspergillus infections in cystic fibrosis",
abstract = "Patients with cystic fibrosis (CF) suffer from chronic lung infection and airway inflammation. Respiratory failure secondary to chronic or recurrent infection remains the commonest cause of death and accounts for over 90{\%} of mortality. Bacteria as Staphylococcus aureus, Pseudomonas aeruginosa and Burkholderia cepacia complex have been regarded the main CF pathogens and their role in progressive lung decline has been studied extensively. Little attention has been paid to the role of Aspergillus spp. and other filamentous fungi in the pathogenesis of non-ABPA (allergic bronchopulmonary aspergillosis) respiratory disease in CF, despite their frequent recovery in respiratory samples. It has become more apparent however, that Aspergillus spp. may play an important role in chronic lung disease in CF. Research delineating the underlying mechanisms of Aspergillus persistence and infection in the CF lung and its link to lung deterioration is lacking. This review summarizes the Aspergillus disease phenotypes observed in CF, discusses the role of CFTR (cystic fibrosis transmembrane conductance regulator)-protein in innate immune responses and new treatment modalities.",
keywords = "aspergillus , aspergillus fumigatus, aspergillosis, cystic fibrosis, allergic bronchopulmonary aspergillosis, CFTR",
author = "Jill King and Brunel, {Shan F} and Adilia Warris",
note = "Hot Topics In Infection And Immunity In Children — Papers from the 13th annual IIC meeting, Oxford, UK, 2015 Conflict of interest None.",
year = "2016",
month = "7",
day = "5",
doi = "10.1016/j.jinf.2016.04.022",
language = "English",
volume = "72",
pages = "S50--S55",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W B SAUNDERS CO LTD",
number = "Supplement 5",

}

TY - JOUR

T1 - Aspergillus infections in cystic fibrosis

AU - King, Jill

AU - Brunel, Shan F

AU - Warris, Adilia

N1 - Hot Topics In Infection And Immunity In Children — Papers from the 13th annual IIC meeting, Oxford, UK, 2015 Conflict of interest None.

PY - 2016/7/5

Y1 - 2016/7/5

N2 - Patients with cystic fibrosis (CF) suffer from chronic lung infection and airway inflammation. Respiratory failure secondary to chronic or recurrent infection remains the commonest cause of death and accounts for over 90% of mortality. Bacteria as Staphylococcus aureus, Pseudomonas aeruginosa and Burkholderia cepacia complex have been regarded the main CF pathogens and their role in progressive lung decline has been studied extensively. Little attention has been paid to the role of Aspergillus spp. and other filamentous fungi in the pathogenesis of non-ABPA (allergic bronchopulmonary aspergillosis) respiratory disease in CF, despite their frequent recovery in respiratory samples. It has become more apparent however, that Aspergillus spp. may play an important role in chronic lung disease in CF. Research delineating the underlying mechanisms of Aspergillus persistence and infection in the CF lung and its link to lung deterioration is lacking. This review summarizes the Aspergillus disease phenotypes observed in CF, discusses the role of CFTR (cystic fibrosis transmembrane conductance regulator)-protein in innate immune responses and new treatment modalities.

AB - Patients with cystic fibrosis (CF) suffer from chronic lung infection and airway inflammation. Respiratory failure secondary to chronic or recurrent infection remains the commonest cause of death and accounts for over 90% of mortality. Bacteria as Staphylococcus aureus, Pseudomonas aeruginosa and Burkholderia cepacia complex have been regarded the main CF pathogens and their role in progressive lung decline has been studied extensively. Little attention has been paid to the role of Aspergillus spp. and other filamentous fungi in the pathogenesis of non-ABPA (allergic bronchopulmonary aspergillosis) respiratory disease in CF, despite their frequent recovery in respiratory samples. It has become more apparent however, that Aspergillus spp. may play an important role in chronic lung disease in CF. Research delineating the underlying mechanisms of Aspergillus persistence and infection in the CF lung and its link to lung deterioration is lacking. This review summarizes the Aspergillus disease phenotypes observed in CF, discusses the role of CFTR (cystic fibrosis transmembrane conductance regulator)-protein in innate immune responses and new treatment modalities.

KW - aspergillus

KW - aspergillus fumigatus

KW - aspergillosis

KW - cystic fibrosis

KW - allergic bronchopulmonary aspergillosis

KW - CFTR

U2 - 10.1016/j.jinf.2016.04.022

DO - 10.1016/j.jinf.2016.04.022

M3 - Article

VL - 72

SP - S50-S55

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - Supplement 5

ER -